Related Experiment Video
Updated: Jan 13, 2026

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Breast implant explantation with mastopexy in patients using GLP-1 receptor agonizts: A retrospective comparative
1Mayanei HaYeshua Medical Centre, affiliated with the Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel; The Dina Recanati School of Medicine Reichman University, Herzliya, Israel.
Background:
Glucagon-like peptide-1 (GLP-1) receptor agonizts are being increasingly prescribed for weight management. Although recent studies suggest variable surgical outcomes in patients using these medications, specific effects on breast surgery remain unclear.
Objectives:
To compare postoperative outcomes following breast implant explantation with mastopexy between patients using GLP-1 receptor agonizts and matched controls.
Methods:
This retrospective comparative case series included 30 patients using GLP-1 receptor agonizts who underwent breast implant explantation with mastopexy, matched 1:1 with 30 control patients based on age, body mass index, and smoking status. Primary outcomes included overall complication rates, wound healing complications, and postoperative infections. Secondary outcomes included weight loss, revision rates, and nutritional parameters.
Results:
GLP-1 patients demonstrated numerically higher overall complication rates compared to the controls (20% vs. 10%, p=0.47). Despite achieving greater weight loss (7.8 kg vs. 0.5 kg, p<0.001), GLP-1 patients experienced more wound healing complications (13.3% vs. 3.3%, p=0.35) and seroma formation (10% vs. 0%, p=0.24). GLP-1 patients had significantly lower serum albumin (4.06 ± 0.22 vs. 4.22 ± 0.17 g/dL, p=0.003) and prealbumin levels (23.52 ± 3.39 vs. 25.55 ± 3.10 mg/dL, p=0.02). No significant differences were observed in infection rates or revision requirements.
Conclusions:
This pilot study indicates that patients using GLP-1 receptor agonizts showed directional trends toward higher complication rates despite achieving significant weight loss. The observed nutritional differences, including low albumin and prealbumin levels, may contribute to increased wound healing complications. These findings suggest potential tissue-specific effects that warrant further investigation and specialized perioperative management protocols for breast surgery patients.
Study Design:
Retrospective Comparative Case Series.
More Related Videos
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
03:55Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma
Published on: December 29, 2023
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Dipeptidyl Peptidase 4 Inhibitors